Your browser doesn't support javascript.
loading
3'-Modification stabilizes mRNA and increases translation in cells.
Gampe, Christian; White, Amy C Seila; Siva, Swetha; Zécri, Frédéric; Diener, John.
Afiliação
  • Gampe C; Novartis Institutes for BioMedical Research, 181 Massachusetts Ave., Cambridge, MA 02139, USA. Electronic address: christian.gampe@novartis.com.
  • White ACS; Novartis Institutes for BioMedical Research, 181 Massachusetts Ave., Cambridge, MA 02139, USA.
  • Siva S; Novartis Institutes for BioMedical Research, 181 Massachusetts Ave., Cambridge, MA 02139, USA.
  • Zécri F; Novartis Institutes for BioMedical Research, 181 Massachusetts Ave., Cambridge, MA 02139, USA.
  • Diener J; Novartis Institutes for BioMedical Research, 181 Massachusetts Ave., Cambridge, MA 02139, USA.
Bioorg Med Chem Lett ; 28(14): 2451-2453, 2018 08 01.
Article em En | MEDLINE | ID: mdl-29907393
ABSTRACT
Successful implementation of mRNA gene therapy is facing many hurdles, for example poor expression levels of the exogenously delivered mRNA transcripts. Herein we describe the synthesis of various 3'-modified RNA oligonucleotides, and we show that 3'-modification drastically stabilizes these oligonucleotides in cell extracts. Modification of the 3'-terminus of gaussia luciferase mRNA results in 3-fold increased and extended (>48 h) translation of the mRNA. Our findings suggest 3'-modification of RNA-transcripts as a valid approach to increase expression levels for application in mRNA gene therapy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transcrição Gênica / RNA Mensageiro / Terapia Genética Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transcrição Gênica / RNA Mensageiro / Terapia Genética Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article